Q1 2026 · 13F-HR
Lynx1 Capital Management LPholdings as filed
Filed 2026-05-04 · accession 0001910456-26-000002
$632.7M
Reported value
23
Positions
2026-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $155.1M | 24.5% | 4,763,673 | Common | SHARED |
| G3855L106 | GHRS | GH RESEARCH PLC | $151.3M | 23.9% | 10,763,288 | Common | SHARED |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $127.4M | 20.1% | 8,963,500 | Common | SHARED |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $88.3M | 14.0% | 2,611,568 | Common | SHARED |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $36.1M | 5.71% | 1,880,303 | Common | SHARED |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $18.4M | 2.91% | 6,998,902 | Common | SHARED |
| 500946108 | KRRO | KORRO BIO INC | $17.4M | 2.75% | 1,538,296 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $8.1M | 1.28% | 8,019,148 | Common | SHARED |
| 98401F105 | XNCR | XENCOR INC | $6.5M | 1.02% | 536,398 | Common | SHARED |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $5.4M | 0.86% | 985,113 | Common | SHARED |
| 702712209 | PASG | PASSAGE BIO INC | $4.9M | 0.77% | 623,704 | Common | SHARED |
| 64136E102 | NEUP | NEUPHORIA THERAPEUTICS INC | $3.6M | 0.56% | 875,328 | Common | SHARED |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $2.7M | 0.42% | 211,689 | Common | SHARED |
| 156944100 | CGON | CG ONCOLOGY INC | $2.1M | 0.34% | 31,591 | Common | SHARED |
| N44445109 | IMTX | IMMATICS N.V | $2.1M | 0.34% | 216,973 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $1.3M | 0.20% | 119,516 | Common | SHARED |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $973,148 | 0.15% | 1,628,700 | Common | SHARED |
| 95075A107 | HOWL | WEREWOLF THERAPEUTICS INC | $547,673 | 0.09% | 657,786 | Common | SHARED |
| 451033708 | IBIO | IBIO INC | $129,344 | 0.02% | 68,076 | Common | SHARED |
| 097702203 | BOLT | BOLT BIOTHERAPEUTICS INC | $124,432 | 0.02% | 30,800 | Common | SHARED |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $110,947 | 0.02% | 68,486 | Common | SHARED |
| 00091E109 | ABSI | ABSCI CORPORATION | $63,735 | 0.01% | 21,245 | Common | SHARED |
| 68232V884 | TRAW | TRAWS PHARMA INC | $27,593 | 0.00% | 15,078 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.